Pearl River Capital, LLC Agios Pharmaceuticals, Inc. Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $391,855 - $461,179	-7,527 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$44.23 - $57.5 $74,173 - $96,427	-1,677 Reduced 18.22%	7,527 $389,000
Q4 2020 Feb 12, 2021	BUY	$33.21 - $46.54 $38,390 - $53,800	1,156 Added 14.36%	9,204 $399,000
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $272,585 - $450,124	8,048 New	8,048 $282,000
Q2 2020 Aug 10, 2020	SELL	$34.45 - $53.48 $31,556 - $48,987	-916 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$31.52 - $53.81 $28,872 - $49,289	916 New	916 $32,000

244

59.9M

270K

332K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.94B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.